The 5-HT(1A) receptor agonist flesinoxan increases aversion in a model of panic-like anxiety in rats

Journal of Psychopharmacology

Volumn 13, Issue 2, 1999, Pages 166-170

  Jenck, François ^a,b   Martin, James R ^a   Moreau, Jean Luc ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

5 HT(1A); Animal model; Anxiety; Brain stimulation; Panic; Periaqueductal grey

Indexed keywords

ALPRAZOLAM; FLESINOXAN; RECEPTOR SUBTYPE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; YOHIMBINE; PIPERAZINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVERSION; CONTROLLED STUDY; DOSE RESPONSE; FEAR; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; ANIMAL; AROUSAL; AVOIDANCE BEHAVIOR; DRUG EFFECT; ELECTROSTIMULATION; WISTAR RAT;

ANIMALS; AROUSAL; AVOIDANCE LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MALE; PANIC; PERIAQUEDUCTAL GRAY; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS;

EID: 0032588698     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119901300209     Document Type: Article

References (39)

1. Allikmets L, Matto V, Harro J (1996) Do the antidepressants have anxiogenic action? Biol Psychiatry 39: 626
2. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviors, respectively. Eur J Pharmacol 264: 259-264
3. Barrett J E, Gleeson S, Nader M A, Hoffmann S M (1989) Anticonflict effects of the 5HT1A compound flesinoxan. J Psychopharmacol 3: 64-69
4. Blanchard D C, Shepherd J K, Rodgers R J, Blanchard R J (1992) Evidence for differential effects of 8-OH-DPAT on male and female rats in the anxiety/defense test battery. Psychopharmacology 106: 531-539
5. 1 receptor agonists administered into the periaqueductal gray. Psychopharmacology 108: 110-114
6. 1A receptors. Br J Pharmacol 115: 203-209
7. Carli M, Samanin R (1988) Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin 1A receptor agonist. Psychopharmacology 94: 84-91
8. Chopin P, Briley M (1987) Animal models of anxiety: the effects of compounds that modify serotonergic function. Trends Pharmacol Sci 8: 383-388
9. 1A ligands in the elevated X-maze and effects of dorsal raphe lesions. Psychopharmacology 106: 484-490
10. Deakin J W F, Graeff F G (1991) 5HT and mechanisms of defence. J Psychopharmacology 5: 305-315
11. De Voogd J M, van den Berg S J (1996) Flesinoxan in generalized anxiety disorder: a meta-analysis of two double-blind, placebo controlled comparisons with alprazolam. Eur Neuropsychopharmacology 6 (Suppl 4): S4-141
12. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121: 1-26
13. 1A receptors in psychopathology and the mechanism of action of clinically effective therapeutic agents. Drug News Perspect 9: 270-280
14. 1A receptors: behavioral and neurochemical pharmacology, pp. 261-267. Ellis Horwood, Chichester
15. Gardner C R (1988) Potential use of drugs modulating 5HT activity in the treatment of anxiety. Gen Pharmacol 19: 347-356
16. 1A agonists effects on punished responding of squirrel monkeys. Pharmacol Biochem Behav 37: 335-337
17. Harro J, Vasar E, Bradwejn J (1993) CCK in animal and human research on anxiety. Trends Pharmacol Sci 14: 224-249
18. 1A (5HT1B or 5HT1C) receptors on periaqueductal gray aversion. Eur J Pharmacol 161: 219-221
19. Jenck F, Moreau J L, Martin J R (1995) Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Res 57: 181-191
20. Jenck F, Moreau J L, Berendsen H H G, Boes M, Broekkamp C L E, Martin J R, Wichmann J, Van Delft A M L (1998) Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats. Eur Neuropsychopharmacol 8: 161-168
21. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J Pharmacol Exp Ther 272: 920-929
22. 1A receptor ligands in a modified Geller-Seifter conflict model in the rat. Eur J Pharmacol 325: 121-128
23. 1A receptor activation. Brain Res 555: 159-163
24. McBlane J W, Handley S L (1994) Effects of two stressors on behavior in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT. Psychopharmacology 116: 173-182
25. 1A receptor-mediated regulation of plasma neuroendocrine hormones. J Pharmacol Exp Ther 271: 1246-1252
26. 1A receptor antagonist (S)-UH-301 in rodents and monkeys. Brain Res Bull 29: 901-904
27. Nashold B S, Wilson W P, Slaughter D G (1969) Sensations evoked by stimulation of the midbrain of man. J Neurosurg 30: 14-24
28. Nogueira R L, Graeff F G (1995) Role of 5HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacol Biochem Behav 52: 1-6
29. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York
30. Redfern W S, Williams A (1995) A re-evaluation of the role of α2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat. Br J Pharmacol 116: 2081-2089
31. 1A receptor agonist, flesinoxan. Pharmacol Biochem Behav 48: 959-963
32. Sanchez C (1993) Effect of serotonergic drugs on footshock-induced ultrasonic vocalisation in adult male rats. Behav Pharmacol 4: 269-277
33. Schipper J, Tulp M T M, Berkelmans B, Mos J, Van der Heijden J A M, Olivier B (1991) Preclinical pharmacology of flesinoxan: a potential anxiolytic and antidepressant drug. Hum Psychopharmacol 6: 53-61
34. Swiss Academy of Medical Sciences and Swiss Academy of Science (1995) Ethical principles and guidelines for experiments on animals. Experientia 51: 1-3
35. Treit D, Robinson A, Rotzinger S, Pesold C (1993) Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test. Behav Brain Res 54: 23-34
36. 1A receptor agonist flesinoxan in panic disorder. Psychopharmacology 127: 174-180
37. Winter J C, Rabin R A (1992) Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. J Pharmacol Exp Ther 263: 682-688
38. Winter J C, Rabin R A (1993) Antagonism of the stimulus effect of yohimbine and 8-hydroxydipropylaminotetralin. Pharmacol Biochem Behav 44: 851-855
39. Zethof T, Van der Heyden J, Tilboom J, Olivier B (1995) Stress-induced hyperthermia as a putative anxiety model. Eur J Pharmacol 294: 125-135